Liquidia Technologies (NASDAQ:LQDA) Announces Quarterly Earnings Results, Misses Expectations By $0.06 EPS

Key Points

• Liquidia Technologies reported quarterly earnings of ($0.49) EPS, missing the consensus estimate of (0.43) by ($0.06).
• The company's revenue increased by 141.5% compared to the same quarter last year, despite having a negative net margin of 903.80%.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Liquidia Technologies, with an average target price of $26.89.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.06), Briefing.com reports. Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. The company's revenue for the quarter was up 141.5% compared to the same quarter last year.

Liquidia Technologies Trading Up 3.7%

NASDAQ LQDA opened at $21.20 on Tuesday. The stock has a market capitalization of $1.81 billion, a price-to-earnings ratio of -13.42 and a beta of 0.14. The stock's 50 day moving average price is $15.68 and its two-hundred day moving average price is $15.23. The company has a debt-to-equity ratio of 2.08, a quick ratio of 2.91 and a current ratio of 2.93. Liquidia Technologies has a 52 week low of $8.26 and a 52 week high of $21.27.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. HC Wainwright boosted their target price on shares of Liquidia Technologies from $29.00 to $35.00 and gave the stock a "buy" rating in a report on Wednesday, May 28th. Wall Street Zen raised shares of Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. BTIG Research restated a "buy" rating on shares of Liquidia Technologies in a report on Tuesday, May 27th. Scotiabank increased their price target on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a report on Wednesday, May 28th. Finally, Oppenheimer set a $13.00 price objective on shares of Liquidia Technologies and gave the stock an "underperform" rating in a research note on Monday, May 19th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $26.89.

Insider Transactions at Liquidia Technologies

In other Liquidia Technologies news, insider Sarah Krepp sold 2,673 shares of the business's stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $38,170.44. Following the sale, the insider owned 142,499 shares in the company, valued at approximately $2,034,885.72. The trade was a 1.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Roger Jeffs sold 20,252 shares of the company's stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $289,198.56. Following the sale, the chief executive officer owned 1,038,560 shares in the company, valued at approximately $14,830,636.80. This represents a 1.91% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 90,277 shares of company stock worth $1,469,392. Corporate insiders own 30.10% of the company's stock.

Institutional Investors Weigh In On Liquidia Technologies

A number of institutional investors and hedge funds have recently made changes to their positions in LQDA. Goldman Sachs Group Inc. raised its stake in shares of Liquidia Technologies by 10.7% during the 1st quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company's stock worth $12,703,000 after purchasing an additional 82,955 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Liquidia Technologies by 15.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company's stock worth $1,796,000 after purchasing an additional 16,022 shares in the last quarter. Creative Planning raised its stake in Liquidia Technologies by 40.7% in the 2nd quarter. Creative Planning now owns 26,840 shares of the company's stock valued at $334,000 after acquiring an additional 7,765 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Liquidia Technologies by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company's stock valued at $556,000 after acquiring an additional 1,700 shares during the period. Institutional investors own 64.54% of the company's stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.